Author Title Type [ Year(Asc)]
Filters: Author is Sandra Uesugi  [Clear All Filters]
2023
Monica L Vermillion Maier, Siddens LK, Pennington JM, Uesugi S, Tilton SC, Vertel EA, Tidwell LG, et al.. Benzo[a]pyrene toxicokinetics in humans following dietary supplementation with 3,3'-diindolylmethane (DIM) or Brussels sprouts. Toxicol Appl Pharmacol. 2023 ;460:116377.
Monica L Vermillion Maier, Siddens LK, Pennington JM, Uesugi S, Labut EM, Vertel EA, Tidwell LG, et al.. Impact of phenanthrene co-administration on the toxicokinetics of benzo[a]pyrene in humans. UPLC-accelerator mass spectrometry following oral microdosing. Chem Biol Interact. 2023 ;382:110608.
2022
Monica L Vermillion Maier, Siddens LK, Pennington JM, Uesugi S, Anderson KA, Tidwell LG, Ognibene TJ, et al.. Benzo[a]pyrene (BaP) metabolites predominant in human plasma following escalating oral micro-dosing with [C]-BaP. Environ Int. 2022 ;159:107045.
2021
Monica L Vermillion Maier, Siddens LK, Uesugi S, Choi J, Leonard SW, Pennington JM, Smith JN, et al.. 3,3'-Diindolylmethane Exhibits Significant Metabolism after Oral Dosing in Humans. Drug Metab Dispos. 2021 ;49(8):694-705.
2019
Madeen EP, Siddens LK, Uesugi S, McQuistan TJ, Corley RA, Smith JN, et al.. Toxicokinetics of benzo[a]pyrene in humans: Extensive metabolism as determined by UPLC-accelerator mass spectrometry following oral micro-dosing. Toxicol Appl Pharmacol. 2019 ;364:97-105.
2018
Hummel JM, Madeen EP, Siddens LK, Uesugi S, McQuistan TJ, Anderson KA, et al.. Pharmacokinetics of [C]-Benzo[a]pyrene (BaP) in humans: Impact of Co-Administration of smoked salmon and BaP dietary restriction. Food Chem Toxicol. 2018 ;115:136-147.
2013
Schure MB, Kile ML, Harding A, Harris S, Uesugi S, R Goins T. Perceptions of the Environment and Health Among Members of the Confederated Tribes of the Umatilla Indian Reservation. Environ Justice. 2013 ;6(3):115-120.